2024 ICD-10-CM Diagnosis Code T80.82XA
Complication of immune effector cellular therapy, initial encounter
- ICD-10-CM Code:
- T80.82XA
- ICD-10 Code for:
- Complication of immune effector cellular therapy, init
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Not chronic
- Code Navigator:
T80.82XA is a billable diagnosis code used to specify a medical diagnosis of complication of immune effector cellular therapy, initial encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.
T80.82XA is an initial encounter code, includes a 7th character and should be used while the patient is receiving active treatment for a condition like complication of immune effector cellular therapy. According to ICD-10-CM Guidelines an "initial encounter" doesn't necessarily means "initial visit". The 7th character should be used when the patient is undergoing active treatment regardless if new or different providers saw the patient over the course of a treatment. The appropriate 7th character codes should also be used even if the patient delayed seeking treatment for a condition.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Cytokine release syndrome
- Cytokine release syndrome due to chimeric antigen receptor T-cell immunotherapy
- Immune effector cell-associated neurotoxicity syndrome
- Immune system complication of procedure
Clinical Classification
Clinical Category is Complication of other surgical or medical care, injury, initial encounter
- CCSR Category Code: INJ037
- Inpatient Default CCSR: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Clinical Information
Cytokine Release Syndrome
a severe immune reaction characterized by excessive release of cytokines. symptoms include dyspnea; fever; headache; hypotension; nausea; rash; tachycardia; hypoxia; hyperferritinemia, and multiple organ failure. it is associated with viral infections, sepsis; autoimmune diseases and a variety of factors used in immunotherapy.
Coding Guidelines
The appropriate 7th character is to be added to each code from block Complications following infusion, transfusion and therapeutic injection (T80). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Replacement Code
T8082XA replaces the following previously assigned ICD-10-CM code(s):
- T80.89XA - Oth comp fol infusion, transfuse and theraputc inject, init
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - Code Added, effective from 10/1/2021 through 9/30/2022
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.